Akihisa Hidaka

Akihisa Hidaka

Auto-generated profile, based on publicly available information

Akihisa Hidaka

Division of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2014 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
AHAkihisa Hidaka
Akihisa Hidaka
SSShizuka Sasazuki
Shizuka Sasazuki
Keitaro MatsuoKeitaro Matsuo
Keitaro Matsuo
HIHidemi Ito
Hidemi Ito
NSNorie Sawada
Norie Sawada
FGfor the JPHC Study Group
for the JPHC Study Group
The association between alcohol consumption, genetic polymorphisms of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) and gastric cancer risk is not completely understood. We investigated the association between ADH1B (rs1229984), ADH1C (rs698) and ALDH2 (rs671) polymorphisms, alcohol consumption and the risk of gastric cancer among Japanese subjects in a population-based, nested, case–control study (1990–2004). Among 36 745 subjects who answered the baseline questionnaire and provided blood samples, 457 new gastric cancer cases matched to 457 controls were used in the analysis. The odds ratios (OR) and corresponding 95% confidence intervals (CI) were calculated using logistic regression models. No association was observed between alcohol consumption, ADH1B (rs1229984), ADH1C (rs698) and ALDH2 (rs671) polymorphisms and gastric cancer risk. However, considering gene–environmental interaction, ADH1C G allele carriers who drink ≥150g/week of ethanol had a 2.5-fold increased risk of gastric cancer (OR = 2.54, 95% CI = 1.05–6.17) relative to AA genotype carriers who drink 0 to <150g/week (P for interaction = 0.02). ALDH2 A allele carriers who drink ≥150g/week also had an increased risk (OR = 2.08, 95% CI = 1.05–4.12) relative to GG genotype carriers who drink 0 to < 150g/week (P for interaction = 0.08). To find the relation between alcohol consumption and gastric cancer risk, it is important to consider both alcohol consumption level and ADH1C and ALDH2 polymorphisms.

28 March 2019 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
Matteo RotaMatteo Rota
Matteo Rota
GAGianfranco Alicandro
Gianfranco Alicandro
CPClaudio Pelucchi
Claudio Pelucchi
RBRosella Bonzi
Rosella Bonzi
PBPaola Bertuccio
Paola Bertuccio
Carlo La VecchiaCarlo La Vecchia
Carlo La Vecchia

6 November 2015 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
AGAtsushi Goto
Atsushi Goto
MNMitsuhiko Noda
Mitsuhiko Noda
NSNorie Sawada
Norie Sawada
MKMasayuki Kato
Masayuki Kato
AHAkihisa Hidaka
Akihisa Hidaka
FGfor the JPHC Study Group
for the JPHC Study Group
Previous studies have reported associations between diabetes and cancer risk. However, specific association of hemoglobin A1c (HbA1c) levels with cancer risk remains inconclusive. We followed 29,629 individuals (11,336 men; 18,293 women) aged 46–80 years who participated in the Japan Public Health Center‐based prospective study who had HbA1c measurements available and were cancer‐free at baseline. Cancer incidence was assessed by systemic surveys. We estimated hazard ratios (HRs) for cancer risk with adjustment for age sex, geographic area, body mass index, smoking status, physical activity, alcohol, coffee, vegetable and total energy consumption, and history of cardiovascular disease. After a median follow‐up of 8.5 years, 1,955 individuals had developed cancer. Higher HbA1c levels within both the non‐diabetic and diabetic ranges in individuals without known diabetes were associated with overall cancer risk. Compared with individuals without known diabetes and HbA1c levels of 5.0–5.4%, the HRs for all cancers were 1.27 (95% confidence interval, 1.07–1.52); 1.01 (0.90–1.14); 1.28 (1.09–1.49); and 1.43 (1.14–1.80) for individuals without known diabetes and HbA1c levels <5.0%, 5.5–5.9%, 6.0–6.4%, and ≥6.5%, respectively, and 1.23 (1.02–1.47) for individuals with known diabetes. The lowest HbA1c group had the highest risk of liver cancer, and HbA1c levels were linearly associated with the risk of all cancers after excluding liver cancer (P for linear trend, 0.004). In conclusion, our findings corroborate the notion that glycemic control in individuals with high HbA1c levels may be important not only to prevent diabetes but also to prevent cancer.

1 December 2015 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
AHAkihisa Hidaka
Akihisa Hidaka
TSTaichi Shimazu
Taichi Shimazu
NSNorie Sawada
Norie Sawada
TYTaiki Yamaji
Taiki Yamaji
MIMotoki Iwasaki
Motoki Iwasaki
STShoichiro Tsugane
Shoichiro Tsugane
Background: Most previous prospective studies in Western countries found no association between consumption of fish and n–3 (ω-3) polyunsaturated fatt

28 July 2014 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
AHAkihisa Hidaka
Akihisa Hidaka
SSShizuka Sasazuki
Shizuka Sasazuki
AGAtsushi Goto
Atsushi Goto
NSNorie Sawada
Norie Sawada
TSTaichi Shimazu
Taichi Shimazu
FGfor the JPHC Study Group
for the JPHC Study Group
To date, the association between diabetes mellitus (DM) and gastric cancer has been controversial, including the underlying mechanism. We investigated the association between plasma diabetic biomarkers (insulin, C‐peptide, and blood glucose) and gastric cancer risk. In addition, homeostasis model assessment of insulin resistance (HOMA‐IR) and homeostasis model assessment of β‐cell function (HOMA‐β) were calculated. A total of 36,745 subjects aged 40–69 years in the Japan Public Health Center‐based prospective study (JPHC) who returned the baseline questionnaire and provided blood samples were followed from 1990 to 2004. In the present analysis, 477 cases and 477 matched controls were used. The odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) for developing gastric cancer were calculated using conditional logistic regression models. Plasma insulin was positively associated with increased risk of gastric cancer; compared to tertile 1, ORs were 1.69 (95% CI = 1.11–2.59) and 2.01 (1.19–3.38) for tertiles 2 and 3, respectively ( p for trend = 0.009). In men, C‐peptide was also positively associated with a significant risk; corresponding ORs were 1.42 (0.85–2.38) and 1.91 (1.03–3.54), respectively ( p for trend = 0.04). These findings were confirmed for blood samples from the fasting group (≥8 hr after a meal). Higher HOMA‐IR was also associated with increased risk, whereas no association was observed for blood glucose. Our findings suggest that Japanese population with higher insulin and C‐peptide levels derived from insulin resistance have an elevated risk of gastric cancer.

14 August 2020 in Cancer Research
Verified
Journal Article
Open access
PDF file
AHAkihisa Hidaka
Akihisa Hidaka
THTabitha A. Harrison
Tabitha A. Harrison
YCYin Cao
Yin Cao
LSLori C. Sakoda
Lori C. Sakoda
RBRichard Barfield
Richard Barfield
UPUlrike Peters
Ulrike Peters
Protective associations of fruits, vegetables, and fiber intake with colorectal cancer risk have been shown in many, but not all epidemiologic studies. One possible reason for study heterogeneity is that dietary factors may have distinct effects by colorectal cancer molecular subtypes. Here, we investigate the association of fruit, vegetables, and fiber intake with four well-established colorectal cancer molecular subtypes separately and in combination. Nine observational studies including 9,592 cases with molecular subtypes for microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and somatic mutations in BRAF and KRAS genes, and 7,869 controls were analyzed. Both case-only logistic regression analyses and polytomous logistic regression analyses (with one control set and multiple case groups) were used. Higher fruit intake was associated with a trend toward decreased risk of BRAF-mutated tumors [OR 4th vs. 1st quartile = 0.82 (95% confidence interval, 0.65–1.04)] but not BRAF-wildtype tumors [1.09 (0.97–1.22); P difference as shown in case-only analysis = 0.02]. This difference was observed in case–control studies and not in cohort studies. Compared with controls, higher fiber intake showed negative association with colorectal cancer risk for cases with microsatellite stable/MSI-low, CIMP-negative, BRAF-wildtype, and KRAS-wildtype tumors (Ptrend range from 0.03 to 3.4e-03), which is consistent with the traditional adenoma-colorectal cancer pathway. These negative associations were stronger compared with MSI-high, CIMP-positive, BRAF-mutated, or KRAS-mutated tumors, but the differences were not statistically significant. These inverse associations for fruit and fiber intake may explain, in part, inconsistent findings between fruit or fiber intake and colorectal cancer risk that have previously been reported. Significance: These analyses by colorectal cancer molecular subtypes potentially explain the inconsistent findings between dietary fruit or fiber intake and overall colorectal cancer risk that have previously been reported.